Activation of Astrocytes by CNTF Induces Metabolic Plasticity and Increases Resistance to Metabolic Insults

High energy demands of neurons make them vulnerable to adverse effects of energy impairment. Recently, astrocytes were shown to regulate the flux of energy substrates to neurons. In pathological situations, astrocytes are activated but the consequences on brain energy metabolism are still poorly characterized. We found that local lentiviral-mediated gene transfer of ciliary neurotrophic factor (CNTF), a cytokine known to activate astrocytes, induced a stable decrease in the glycolytic flux in the rat striatum in vivo as measured by 2-[18F]-2-deoxy-d-glucose autoradiography and micro-positron emission tomography imaging. The activity of the mitochondrial complex IV enzyme cytochrome oxidase was not modified, suggesting maintenance of downstream oxidative steps of energy production. CNTF significantly increased the phosphorylation level of the intracellular energy sensor AMP-activated protein kinase (AMPK), supporting a specific reorganization of brain energy pathways. Indeed, we found that different key enzymes/transporters of fatty acids β-oxidation and ketolysis were overexpressed by CNTF-activated astrocytes within the striatum. In primary striatal neuron/astrocyte mixed cultures exposed to CNTF, the AMPK pathway was also activated, and the rate of oxidation of fatty acids and ketone bodies was significantly enhanced. This metabolic plasticity conferred partial glial and neuronal protection against prolonged palmitate exposure and glycolysis inhibition. We conclude that CNTF-activated astrocytes may have a strong protective potential to face severe metabolic insults.

[1]  M. Febbraio,et al.  CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK , 2006, Nature Medicine.

[2]  N. Auestad,et al.  Fatty Acid Oxidation and Ketogenesis by Astrocytes in Primary Culture , 1991, Journal of neurochemistry.

[3]  B. Harper Huntington Disease , 2005, Journal of the Royal Society of Medicine.

[4]  S. Kügler,et al.  Adenovirus-Mediated GDNF and CNTF Pretreatment Protects against Striatal Injury Following Transient Middle Cerebral Artery Occlusion in Mice , 2001, Neurobiology of Disease.

[5]  N. Déglon,et al.  Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease , 2001, Neurobiology of Disease.

[6]  M. Guzmán,et al.  Is there an astrocyte–neuron ketone body shuttle? , 2001, Trends in Endocrinology & Metabolism.

[7]  M. Peschanski,et al.  Corticostriatopallidal Neuroprotection by Adenovirus-Mediated Ciliary Neurotrophic Factor Gene Transfer in a Rat Model of Progressive Striatal Degeneration , 2002, The Journal of Neuroscience.

[8]  Y. Izumi,et al.  beta-Hydroxybutyrate fuels synaptic function during development. Histological and physiological evidence in rat hippocampal slices. , 1998, The Journal of clinical investigation.

[9]  G. Bonvento,et al.  Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: A confocal microscopy study , 1998, Glia.

[10]  J. Edmond Energy metabolism in developing brain cells. , 1992, Canadian journal of physiology and pharmacology.

[11]  M. L. de Ceballos,et al.  The AMP‐Activated Protein Kinase Is Involved in the Regulation of Ketone Body Production by Astrocytes , 1999, Journal of neurochemistry.

[12]  G. Yancopoulos,et al.  Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Kálmán Glial reaction and reactive glia , 2003 .

[14]  J. de Vellis,et al.  Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture , 1987, Journal of neuroscience research.

[15]  A. Nehlig,et al.  Basal levels of metabolic activity are elevated in Genetic Absence Epilepsy Rats from Strasbourg (GAERS): measurement of regional activity of cytochrome oxidase and lactate dehydrogenase by histochemistry , 2003, Experimental Neurology.

[16]  P Aebischer,et al.  Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. , 2000, Human gene therapy.

[17]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[18]  M. Vila,et al.  D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. , 2003, The Journal of clinical investigation.

[19]  J. Phillis,et al.  A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders , 2004, Brain Research Reviews.

[20]  N. Bazan,et al.  Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. , 1970, Biochimica et biophysica acta.

[21]  Britton Chance,et al.  Ketone Bodies, Potential Therapeutic Uses , 2001, IUBMB life.

[22]  Myriam Schluep,et al.  Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients , 1996, Nature Medicine.

[23]  N. Bazan CHANGES IN FREE FATTY ACIDS OF BRAIN BY DRUG‐INDUCED CONVULSIONS, ELECTROSHOCK AND ANAESTHESIA , 1971, Journal of neurochemistry.

[24]  S. Wiegand,et al.  Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Farmerie,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Anorectic Effects of the Cytokine, Ciliary Neurotropic Factor, Are Mediated by Hypothalamic Neuropeptide Y: Comparison with Leptin* , 2022 .

[26]  J. Bloch,et al.  Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. , 2000, Human gene therapy.

[27]  B. Smith Dehydrogenase activity in reactive and neoplastic astrocytes. , 1963, Brain : a journal of neurology.

[28]  A. Nehlig,et al.  Quantitative histochemical changes in enzymes involved in energy metabolism in the rat brain during postnatal development. II. Glucose-6-phosphate dehydrogenase and β-hydroxybutyrate dehydrogenase , 1992, International Journal of Developmental Neuroscience.

[29]  L. Sokoloff Metabolism of ketone bodies by the brain. , 1973, Annual review of medicine.

[30]  M. Febbraio,et al.  Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues. , 2006, Endocrinology.

[31]  Philippe Hantraye,et al.  Ciliary Neurotrophic Factor Activates Astrocytes, Redistributes Their Glutamate Transporters GLAST and GLT-1 to Raft Microdomains, and Improves Glutamate Handling In Vivo , 2006, The Journal of Neuroscience.

[32]  G. Bonvento,et al.  Decreased metabolic response to visual stimulation in the superior colliculus of mice lacking the glial glutamate transporter GLT‐1 , 2005, The European journal of neuroscience.

[33]  N. Robinson,et al.  Ultrastructural study of enzymes in reactive astrocytes: Clarification of astrocytic activity , 1982, The Histochemical Journal.

[34]  G. Velasco,et al.  Role of Carnitine Palmitoyltransferase I in the Control of Ketogenesis in Primary Cultures of Rat Astrocytes , 1998, Journal of neurochemistry.

[35]  C. Marie,et al.  Protective Action of 1,3-Butanediol in Cerebral Ischemia. A Neurologic, Histologic, and Metabolic Study , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  P. Magistretti,et al.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Welker,et al.  Glial Glutamate Transporters Mediate a Functional Metabolic Crosstalk between Neurons and Astrocytes in the Mouse Developing Cortex , 2003, Neuron.

[38]  I. Galve-Roperh,et al.  De novo‐synthesized ceramide signals apoptosis in astrocytes via extracellular signal‐regulated kinase , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  D. Hardie,et al.  AMP‐activated protein kinase – development of the energy sensor concept , 2006, The Journal of physiology.

[40]  J. Greene,et al.  Characterization of the Excitotoxic Potential of the Reversible Succinate Dehydrogenase Inhibitor Malonate , 1995, Journal of neurochemistry.

[41]  G. Yancopoulos,et al.  Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Lipton,et al.  Ischemic cell death in brain neurons. , 1999, Physiological reviews.

[43]  R. Cortese,et al.  Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Magistretti,et al.  Cell-specific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy , 2000, Neuroscience.

[45]  C. Casiano,et al.  Palmitic and stearic fatty acids induce caspase‐dependent and ‐independent cell death in nerve growth factor differentiated PC12 cells , 2003, Journal of neurochemistry.

[46]  R. Haller,et al.  Energy Contribution of Octanoate to Intact Rat Brain Metabolism Measured by 13C Nuclear Magnetic Resonance Spectroscopy , 2003, The Journal of Neuroscience.